HEXO Corp. announces that on October 29, 2019, it filed its annual report for the fiscal year ended July 31, 2019 on Form 40-F (as amended, including through the Form 40-F/A filed on October 31, 2019, the “2019 Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”).
HEXO Corp. today reported its financial results for the fourth quarter and fiscal year ended July 31, 2019.
HEXO Corp is pleased to announce it has received licences from Health Canada for its cannabis Centre of Excellence in Belleville, Ontario, for research, and for the sale of cannabis topicals, extracts, edibles and beverages from its flagship Gatineau campus.
Want to keep in touch? We’ll send you our latest updates. You can unsubscribe at any time.